*1.Please list your first name, last name, and email:(Required.)

First name:

Last name:

Email:

*2.What is your specialty?(Required.)

*3.How many patients with colorectal cancer do you treat each week?(Required.)

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

*4.The DNA polymerase epsilon (POLE) protein coding gene is associated with DNA mismatch repair.(Required.)

True

False

*5.What is the tumor mutation burden (TMB, in mutations/megabase) cutoff for which there is an FDA indication for pembrolizumab in progressive solid tumors?(Required.)

>5 mut/Mb

>10 mut/Mb

>15 mut/Mb

>20 mut/Mb